GlassScriptPhysician profile
Dennis C Crawford
NPI 1861408312
$69,346.67
in general payments reported to CMS, 2019-2025
9 companies · $32K in 2025
The $32K reported for 2025 was more than what 93% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,705 · 2020: $9,165 · 2021: $9,278 · 2022: $2,253 · 2023: $4,898 · 2024: $5,772 · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $40K · Food and Beverage: $2,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,488.67 |
| Food and Beverage | $2,456.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Moximed, INC | $28,155.89 | 2023-2025 | Misha Knee System, Small, Left, Misha Knee System |
| Joint Restoration Foundation, INC. | $24,267.64 | 2019-2025 | |
| Arthrex, INC. | $7,474.94 | 2019-2024 | Arthrex |
| Vericel Corporation | $6,064.56 | 2020-2021 | |
| Steelhead Surgical INC | $3,353.24 | 2019-2023 | |
| Left Coast Surgical INC | $30.40 | 2025 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Crawford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.